Immune Defense Protein Impact On Respiratory Immune Outcomes
NCT07431840
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals during the cold and flu season. Secondary aims include observing the product's effect on rescue medication use, quality of life, and overall tolerability. This is conducted as a consumer-driven, decentralized observational clinical research study in adults aged 60 or older, using self-reported measures and questionnaires completed at home via the Chloe App.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Upper Respiratory Disease
- Influenza
- Viral Upper Respiratory Infection
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Quantec Ltd
- Last updated on ClinicalTrials.gov
- March 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- People Science, Inc. · Los Angeles, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.